Although COVID-19 patients did develop severe lymphopenia in response to T cell exhaustion, an elevated proportion of HLA-DR+CD38+ CD8+ T cells suggests a potent adaptive immune response in these patients (29). This evidence concerns the gene CD38 and COVID-19.